NCT00492466View on ClinicalTrials.gov

Investigating if Interferon-Beta Can be Used in Patients With MS After They Have Developed Neutralizing Antibodies

PHASE4CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

March 31, 2003

Primary Completion Date

August 31, 2006

Study Completion Date

August 31, 2006

Conditions
Relapsing-Remitting Multiple Sclerosis
Interventions
DRUG

Interferon-beta-1a

dosage and frequency as per label

DRUG

methylprednisolone

dosage and frequency as per Biogen Idec protocol

Trial Locations (1)

Unknown

Coordinating Research Site, Turku

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY